Our next Research in Progress Seminar is scheduled to take place on Thursday, March 31 in the Goldman International Conference Center. The speaker will be Philippe Marambaud, PhD, associate investigator in the Center for Alzheimer’s Disease and Memory Disorders at the Feinstein Institute for Medical Research. Dr. Marambaud will be discussing “Drug repurposing in hereditary hemorrhagic telangiectasia (HHT)”.
Target Audience: Researchers, Students, Hospital-based physicians, Housestaff, Nurses, and Community physicians.
CME Accreditation: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.
Credit Designation: Northwell Health designates this live activity for a maximum of .5 AMA PRA Category 1 Credit. Each physician should only claim credit commensurate with the extent of their participation in the activity.
Goal: The overall goal for the RSC (Regularly Scheduled Conference) is to inform physicians of new developments in understanding basic mechanisms of disease and novel therapeutics that capitalize on a deeper appreciation of disease pathophysiology.
Disclosure Policy: Northwell Health adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by Northwell Health for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.